New Cancer Drug Shows 'Unprecedented' Success in Small Trial

A new rectal cancer drug, Dostarlimab, had incredible success in a small trial of 18 patients—all cancer patients' tumors disappeared.

Related Keywords

New York ,United States ,Memorial Sloan Kettering Cancer Center ,Andrea Cercek ,Sloan Kettering ,Luis Alberto Diaz Jr ,England Journal ,New York City ,Sloan Kettering Cancer ,Section Head ,Colorectal Cancer ,Memorial Sloan Kettering ,Alberto Diaz ,Solid Tumor Oncology , ,